Search IPOs
Grey Market Premium · Jan 28 – Jan 30, 2026 · Issue Price ₹129
The Accretion Nutraveda IPO GMP today is ₹68.00, indicating 52.7% expected listing gain.
The Accretion Nutraveda IPO Grey Market Premium (GMP) is currently trading at ₹68.00 in the unofficial grey market. Based on this, the expected listing price is ₹197.00, implying a +52.7% gain over the issue price of ₹129. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Grey market premium over time (₹)
Latest 15 data points, most recent first
| Date / Time | GMP (₹) | Exp. Listing | Exp. Gain |
|---|---|---|---|
| Feb 04, 2026 12:07 pm | +₹68.00 | ₹197.00 | +52.7% |
| Feb 03, 2026 2:45 pm | +₹68.00 | ₹197.00 | +52.7% |
| Feb 02, 2026 2:17 pm | +₹17.00 | ₹146.00 | +13.2% |
| Feb 01, 2026 9:26 pm | +₹6.00 | ₹135.00 | +4.7% |
| Jan 31, 2026 2:58 pm | +₹6.00 | ₹135.00 | +4.7% |
| Jan 30, 2026 3:09 pm | +₹4.00 | ₹133.00 | +3.1% |
| Jan 29, 2026 5:26 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 28, 2026 4:40 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 27, 2026 4:56 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 26, 2026 2:57 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 25, 2026 4:09 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 24, 2026 6:47 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 23, 2026 2:21 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 22, 2026 6:53 pm | +₹0.00 | ₹129.00 | +0.0% |
| Jan 21, 2026 4:53 pm | +₹0.00 | ₹129.00 | +0.0% |
Want to understand how GMP works and how to estimate listing price? Read our guide on What is GMP in IPO.
The current Grey Market Premium for Accretion Nutraveda IPO is ₹68.00 as of Feb 04, 2026. Expected listing price: ₹197.00, expected gain: 52.7%. GMP data is updated periodically from grey market sources.
A GMP of ₹68.00 means that in the unofficial grey market, Accretion Nutraveda IPO shares are trading at ₹68.00 above the issue price. With an issue price of ₹129, this implies an expected listing at ₹197.00 (52.7% gain). GMP is purely indicative and actual listing price depends on market conditions.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Accretion Nutraveda IPO is expected to list on February 04, 2026 on BSE SME platform. The GMP on listing day is a strong short-term indicator of opening price.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.
